Drug Trial Radar · NCT03059992
Study to Evaluate the Efficacy and Safety of Ibrexafungerp in Patients With Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal Treatment
Last checked: Nov 20, 2026Latest source record: Nov 20, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
233
Actual
Start
Apr 1, 2017
Primary completion
Aug 25, 2023
Study completion Aug 25, 2023
Sponsor
- Lead sponsor
- Scynexis, Inc.Industry
- Sponsor type
- Industry
- First posted
- Feb 23, 2017
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multicenter, open label, non-comparator, single arm study to evaluate the efficacy and safety of ibrexafungerp (SCY-078) in patients ≥ 18 years of age with a documented fungal disease that has been intolerant or refractory (rIFI) to Standard of Care (SoC) antifungal treatment.
Conditions
- Invasive Candidiasis
- Mucocutaneous Candidiasis
- Coccidioidomycosis
- Histoplasmosis
- Blastomycosis
- Chronic Pulmonary Aspergillosis
- Allergic Bronchopulmonary Aspergillosis
- Invasive Pulmonary Aspergillosis
- Recurrent Vulvovaginal Candidiasis
- Other Emerging Fungi
Interventions
IbrexafungerpDrug
Experimental Study Drug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants Who Achieve a Global Response as Determined by the Data Review Committee (DRC) by Fungal Disease.Time frame: Vulvovaginal Candidiasis: Day 17. Chronic Mucocutaneous Candidiasis: EOT up to Day 84. Chronic Pulmonary Aspergillus and Allergic Bronchopulmonary Aspergillosis: EOT up to Day 90. All other diseases: EOT up to Day 180. All Days measured from Baseline.
Locations
37 sites in 8 countries. Site status is shown where the registry gives one.
University of Alabama at Birmingham
Birmingham, Alabama
UC Davis Medical Center
Sacramento, California
University of California San Francisco
San Francisco, California
Emory University Hospital Midtown
Atlanta, Georgia
Augusta University
Augusta, Georgia
Massachusetts General Hospital
Boston, Massachusetts
University of Michigan
Ann Arbor, Michigan
Wayne State University
Detroit, Michigan
University of Minnesota
Minneapolis, Minnesota
Mayo Clinic
Rochester, Minnesota
Washington University School of Medicine
St Louis, Missouri
Memorial Sloan Kettering Cancer Center
New York, New York
Weill Cornell Medical College
New York, New York
Stony Brook University Medical Center
Stony Brook, New York
Duke University Medical Center
Durham, North Carolina
Wake Forest Baptist Medical Center
Winston-Salem, North Carolina
University of Pittsburg Medical Center
Pittsburgh, Pennsylvania
University of Texas Southwestern Medical Center Dallas
Dallas, Texas
University of Texas Health Science Center at Houston
Houston, Texas
University of Wisconsin
Madison, Wisconsin
Medical University of Graz Department of Internal Medicine, Department of Pulmology, Section for Infectious Disease and Tropical Medicine
Graz, Austria
Medical University Innsbruck
Innsbruck, Austria
Universitätsklinikum Köln, Klinik I für Innere Medizin
Cologne, Germany
Universitätsklinikum Essen, Klinik für Infektiologie
Essen, Germany
Universitätsklinikum Frankfurt, Department of Internal Medicine II
Frankfurt, Germany
Klinikum St. Georg gGmbH Department for Infectious Disease, Tropical Medicine and Nephrology
Leipzig, Germany
LMU Klinikum der Universität München, Medizinische Klinik und Poliklinik III
Munich, Germany
Radboud University Medical Center, Department of Medicine Geert Grooteplein Zuid 8
Nijmegen, Gelderland, Netherlands
Aga Khan University
Karachi, Pakistan
Emmed Research
Pretoria, South Africa
Johese Clinical Research
Lyttelton, Centurion, South Africa
Into Research
Groenkloof, Pretoria, South Africa
FCRN Clinical Trial Centre
Three Rivers, Vereeniging, South Africa
Hospital General Universitario Gregorio Marañón
Madrid, Spain
Hospital Universitari i Politecnic La Fe
Valencia, Spain
St. George's University of London
London, United Kingdom
The University of Manchester
Manchester, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.